Use the Back button in your browser to see the other results of your search or to select another record.
| Effect of visceral manipulation on menstrual complaints in women with polycystic ovarian syndrome |
| Yosri MM, Hamada HA, Yousef AM |
| Journal of Osteopathic Medicine 2022 May;122(8):411-422 |
| clinical trial |
| 6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
CONTEXT: Research is lacking regarding osteopathic approaches in treating polycystic ovary syndrome (PCOS), one of the prevailing endocrine abnormalities in reproductive-aged women. Limited movement of pelvic organs can result in functional and structural deficits, which can be resolved by applying visceral manipulation (VM). OBJECTIVES: This study aims to analyze the effect of VM on dysmenorrhea, irregular, delayed, and/or absent menses, and premenstrual symptoms in PCOS patients. METHODS: Thirty Egyptian women with PCOS, with menstruation-related complaints and free from systematic diseases and/or adrenal gland abnormalities, prospectively participated in a single-blinded, randomized controlled trial. They were recruited from the women's health outpatient clinic in the faculty of physical therapy at Cairo University, with an age of 20 to 34 years, and a body mass index (BMI) >= 25, < 30 kg/m2. Patients were randomly allocated into two equal groups (15 patients); the control group received a low-calorie diet for 3 months, and the study group that received the same hypocaloric diet added to VM to the pelvic organs and their related structures, according to assessment findings, for eight sessions over 3 months. Evaluations for body weight, BMI, and menstrual problems were done by weight-height scale, and menstruation-domain of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ), respectively, at baseline and after 3 months from interventions. Data were described as mean, standard deviation, range, and percentage whenever applicable. RESULTS: Of 60 Egyptian women with PCOS, 30 patients were included, with baseline mean age, weight, BMI, and menstruation domain score of 27.5 +/- 2.2 years, 77.7 +/- 4.3 kg, 28.6 +/- 0.7 kg/m2, and 3.4 +/- 1.0, respectively, for the control group, and 26.2 +/- 4.7 years, 74.6 +/- 3.5 kg, 28.2 +/- 1.1 kg/m2, and 2.9 +/- 1.0, respectively, for the study group. Out of the 15 patients in the study group, uterine adhesions were found in 14 patients (93.3%), followed by restricted uterine mobility in 13 patients (86.7%), restricted ovarian/broad ligament mobility (9, 60%), and restricted motility (6, 40%). At baseline, there was no significant difference (p > 0.05) in any of demographics (age, height), or dependent variables (weight, BMI, menstruation domain score) among both groups. Poststudy, there was a statistically significant reduction (p = 0.000) in weight, and BMI mean values for the diet group (71.2 +/- 4.2 kg, and 26.4 +/- 0.8 kg/m2, respectively) and the diet plus VM group (69.2 +/- 3.7 kg; 26.1 +/- 0.9 kg/m2, respectively). For the improvement in the menstrual complaints, a significant increase (p < 0.05) in the menstruation domain mean score was shown in diet group (3.9 +/- 1.0), and the diet plus VM group (4.6 +/- 0.5). On comparing both groups poststudy, there was a statistically significant improvement (p = 0.024) in the severity of menstruation-related problems in favor of the diet plus VM group. CONCLUSIONS: VM yielded greater improvement in menstrual pain, irregularities, and premenstrual symptoms in PCOS patients when added to caloric restriction than utilizing the low-calorie diet alone in treating that condition.
|